Pharmaceutical - Anti-virals

Filter

Current filters:

Anti-virals

Popular Filters

226 to 250 of 307 results

UK to implement child flu vaccines program

25-07-2012

UK Health Secretary Andrew Lansley yesterday accepted recommendations from UK immunization experts to…

Anti-viralsAstraZenecaFluenzHealthcarePharmaceuticalVaccines

More than 150 ARVs available through PEPFAR for global HIV/AIDS relief

24-07-2012

US Food and Drug Administration Commissioner Margaret Hamburg says that the agency has approved or tentatively…

Anti-viralsGenericsGlobalPharmaceuticalRegulation

Merck & Co in-licenses Chimerix antiviral; Fiocruz to make ARVs in Africa

24-07-2012

USA-based Chimerix, a venture-funded biotech focused on developing novel oral antivirals, has announced…

Anti-viralsChimerixCMX001CMX157FiocruzGlobalLicensingMarkets & MarketingMerck & CoPharmaceuticalRest of the World

DNDi and Cipla to develop 4-in-1 pediatric antiretroviral drug combination

24-07-2012

Coinciding with the XIX International AIDS Conference in Washington DC, the Drugs for Neglected Diseases…

Anti-viralsCiplaGenericsGlobalPharmaceuticalResearch

US govt plans innovative public-private partnerships to turn the tide in fight against HIV/AIDS

23-07-2012

In a speech at the opening session of the XIX International AIDS Conference (AIDS 2012) in Washington…

Anti-viralsBiotechnologyHealthcareNorth AmericaPharmaceutical

Domestic HIV funding outpaces international investments

19-07-2012

A new report by the Joint United Nations Program on HIV/AIDS (UNAIDS) shows that domestic funding for…

Anti-viralsFinancialGlobalHealthcarePharmaceutical

Sanofi Pasteur starts shipping Fluzone in USA for 2012-2013 flu season

17-07-2012

The first lots of Fluzone vaccine have began shipping to US health care providers following Food and…

Anti-viralsFluzoneMarkets & MarketingNorth AmericaPharmaceuticalSanofiSanofi PasteurVaccines

FDA approves Truvada, first drug for reducing the risk of sexually acquired HIV infection

17-07-2012

Despite protests from consumer groups such as the AIDS Healthcare Foundation (AHF), the US Food and Drug…

Anti-viralsBiotechnologyGilead SciencesNorth AmericaPharmaceuticalRegulationTruvada

J&J'S rilpivirine also proven for combination HIV product, says IQWiG

13-07-2012

Since the start of 2012, a new drug - rilpivirine from US health care giant Johnson & Johnson (NYSE:…

Anti-viralsEuropeEvipleraJohnson & JohnsonPharmaceuticalPricingRegulationrilpivirine

Antivirals market facing generics threat, especially for HIV drugs

03-07-2012

Generic copies of branded drugs are predicted to take over the antiviral drugs market, especially in…

Anti-viralsGenericsMarkets & MarketingPatentsPharmaceutical

Latin America progress and challenges in expanding access to HIV treatment highlighted by PAHO

28-06-2012

A number of countries in Latin America and the Caribbean - including Argentina, Brazil, Chile, Cuba,…

Anti-viralsBiotechnologyHealthcarePharmaceuticalSouth America

Incivek and Victrelis important advances in HCV, but still unmet needs

20-06-2012

Nearly two-thirds of US surveyed physicians have seen an increase in the hepatitis C (HCV) patients they…

Anti-viralsIncivekMarkets & MarketingMerck & CoNorth AmericaPharmaceuticalRocheVertexVictrelis

Teva gets rights to BioAlliance's Sitavig in Israel

14-06-2012

French drugmaker BioAlliance Pharma (Euronext Paris: BIO) has signed an exclusive license agreement for…

Anti-viralsBioAlliance PharmaLicensingPharmaceuticalRest of the WorldSitavigTeva Pharmaceutical Industries

Incivek and Victrelis have collectively penetrated over three-quarters of the US genotype 1 HCV market

07-06-2012

One year post launch, Vertex's (Nasdaq: VRTX) Incivek (telaprevir) and Merck & Co (NYSE: MRK) and Roche's…

Anti-viralsIncivekMarkets & MarketingMerck & CoNorth AmericaPharmaceuticalRocheVertexVictrelis

Scientists report new approach to attack flu virus

28-05-2012

An international research team has manufactured a new protein that can combat deadly flu epidemics. The…

Anti-viralsPharmaceuticalResearch

Tanzanian drugmaker to start producing ARVs in August

23-05-2012

Tanzania Pharmaceutical Industries (TPI) was due to start productions earlier this year, but finalization…

Anti-viralsGenericsMarkets & MarketingPharmaceuticalRest of the WorldTanzania Pharma Industries

US House of Representatives trumps Administration on Global AIDS budgets

22-05-2012

The US House of Representatives has budgeted $193 million more to global AIDS programs in the 2013 Foreign…

Anti-viralsFinancialHealthcareNorth AmericaPharmaceuticalPolitics

All "baby boomers" should be tested once for hepatitis C, says USA's CDC

21-05-2012

On the eve of the first ever National Hepatitis Testing Day (May 19), the US Centers for Disease Control…

Anti-viralsHealthcareNorth AmericaPharmaceuticalRegulation

US FDA fast-tracks Achillion's hepatitis C drug candidate

15-05-2012

USA-based Achillion Pharmaceuticals (Nasdaq: ACHN) says it has received Fast Track designation from the…

Achillion PharmaceuticalsAnti-viralsNorth AmericaPharmaceuticalRegulation

FDA advisory thumbs up for Gilead's once-daily Quad for HIV

14-05-2012

There was more good news for Gilead Sciences (Nasdaq: GILD), the world's largest maker of HIV drugs,…

Anti-viralsBiotechnologyGilead SciencesNorth AmericaPharmaceuticalQuadRegulation

226 to 250 of 307 results

Back to top